MRI diffusion in Parkinson's disease: Using the technique's inherent directional information to study the olfactory bulb and substantia Nigra

Journal of Parkinson's Disease

Volumn 2, Issue 2, 2012, Pages 171-180

  Skorpil, Mikael ^a   Söderlund, Veli ^b   Sundin, Anders ^a,b   Svenningsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

diffusion tensor imaging; magnetic resonance imaging; olfactory agnosia; Olfactory bulb; olfactory nerve; substantia nigra

Indexed keywords

CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; IOFLUPANE I 123; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; DRUG BINDING; FEMALE; FRACTIONAL ANISOTROPY; HOEHN AND YAHR; HUMAN; INHERENT DIRECTIONAL INFORMATION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OLFACTORY BULB; PARKINSON DISEASE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; SMELLING; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; UNIVERSITY OF PENNSYLVANIA SMELL IDENTIFICATION TEST;

ADULT; AGED; ANISOTROPY; CORPUS CALLOSUM; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OLFACTION DISORDERS; OLFACTORY BULB; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA;

EID: 84864699243     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-2012-12091     Document Type: Article

References (20)

1. Schapira AH, & Tolosa E (2010) Molecular and clinical prodrome of Parkinson disease: Implications for treatment. Nat Rev Neurol, 6(6), 309-317.
2. Braak H, Ghebremedhin E, Rüb U, Bratzke H, & Del Tredici K (2004) Stages in the development of Parkinson's diseaserelated pathology. Cell Tissue Res, 318(1), 121-134.
3. Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, JaschkeW,Wenning GK,&PoeweW(2006 Feb) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain, 129(Pt 2), 538-542.
4. Skorpil M, Rolheiser T, Robertson H, Sundin A, &Svenningsson P (2011) Diffusion tensor fiber tractography of the olfactory tract. Magn Reson Imaging, 29(2), 289-292.
5. Le Bihan D, Poupon C, Amadon A, & Lethimonnier F (2006) Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging, 24(3), 478-488.
6. Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, & Little DM (2009) Highresolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology, 72(16), 1378-1384.
7. Morton RJ, Guy MJ, Clauss R, Hinton PJ, Marshall CA, & Clarke EA (2005) Comparison of different methods of DatSCAN quantification. Nucl Med Commun, 26(12), 1139-1146.
8. Doty RL, Shaman P, & Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test of olfactory function. Physiol Behav, 32(3), 489-502.
9. Boelmans K, Bodammer NC, Suchorska B, Kaufmann J, Ebersbach G, Heinze H-J, & Niehaus L (2010) Diffusion tensor imaging of the corpus callosum differentiates corticobasal syndrome from Parkinson's disease. Parkinsonism Relat Disord, 16(8), 498-502.
10. Hofer S, & Frahm J (2006) Topography of the human corpus callosum revisited - Comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage, 32, 989-994.
11. Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Osio M, Ciceri E, Albanese A, & Bruzzone MG (2009) White matter involvement in idiopathic Parkinson disease: A diffusion tensor imaging study. AJNR Am J Neuroradiol, 30(6), 1222-1226.
12. Vollmar C, O'Muircheartaigh J, Barker GJ, Symms MR, Thompson P,KumariV, Duncan JS, RichardsonMP,&Koepp MJ (2010) Identical, but not the same: Intra-site and inter-site reproducibility of fractional anisotropy measures on two 3.0 T scanners. Neuroimage, 51(4), 1384-1394.
13. Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C, Khan NM, Leslie RA, & Robertson HA (2011) Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. J Neurol, 258(7), 1254-1260.
14. Trip SA, Wheeler-Kingshott C, Jones SJ, Li WY, Barker GJ, Thompson AJ, Plant GT, & Miller DH (2006) Optic nerve diffusion tensor imaging in optic neuritis. Neuroimage, 30(2), 498-505.
15. Unger MM, Belke M, Menzler K, Heverhagen JT, Keil B, Stiasny-Kolster K, Rosenow F, Diederich NJ, Mayer G, Möller JC, Oertel WH, & Knake S (2010) Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions. Sleep, 33(6), 767-773.
16. Stern MB, Lang A,&PoeweW(2012) Toward a Redefinition of Parkinson's Disease. Mov Disord, 27(1), 54-60.
17. Jones DK, & Cercignani M (2010) Twenty-five pitfalls in the analysis of diffusion MRI data. NMR Biomed, 23(7), 803-820.
18. Adachi M, Hosoya T, Haku T, Yamaguchi K, & Kawanami T (1999) Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. AJNR Am J Neuroradiol, 20(8), 1500-1506.
19. Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, & Poewe W (2005) Voxel-wise analysis of [123I]-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain, 128(Pt 7), 1605-1612.
20. Ibarretxe-Bilbao N, Junque C, Marti MJ, Valldeoriola F, Vendrell P, Bargallo N, Zarei M, & Tolosa E (2010) Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study. Mov Disord, 25(12), 1888-1894.